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Introduction
Current methods of intact tissue structural analysis 
are incompatible with most methods of molecular 
phenotyping, leading to difficulty in gaining a 
perspective on a tissue which includes both its 
structural and molecular level information. 
The barrier to the visualization of intact systems is 
the lipid bilayers in biological tissues, which hinder 
our molecular probing and limit our ability to image 
the tissue by rendering the tissue opaque.1
Removing them is challenging because of their 
importance for the structural integrity of the tissue. 
The CLARITY technique is a tissue clearing 
method to allow for both structural and 
molecular analysis of a tissue sample. By 
attaching the biomolecules within a sample to a 
hydrogel matrix, we preserve the tissue’s 
structure. From there, the unattached lipids can be 
drained, making the tissue optically transparent.1
The now transparent tissue is permeable to light 
and macromolecules, and is able to undergo 
immunostaining and 3D imaging.
Unfortunately, whole tissue or whole body 
CLARITY is very expensive and time 
consuming, taking weeks or months to complete 
the process, limiting the efficiency of work that can 
be done. 
Thick Slice CLARITY
Because of the inherent limitations of thin slice 
immunohistochemistry (IHC) methods and the 
cost, both financially and in terms of time, of whole 
organ/body CLARITY, Xiaochen Lu developed 
Thick Slice CLARITY in the lab of Lisa Stubbs at 
the Carl R. Woese Institute for Genomic Biology at 
the University of Illinois at Urbana-Champaign. 
Thick Slice CLARITY takes the clearing and 
antibody staining principles of whole organ 
CLARITY and applies it instead to 200μm thick 
slices of brain tissue. 
Current Work
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Future Work
Fig. 1, Above, a mouse brain before and after CLARITY technique, 
by K. Chung and K. Deisseroth, Howard Hughes Medical Institute/Stanford
The localization of GPR3 with the CLARITY 
technique has made future work on the 
exercise project actionable. It will lead to 
further localization and other efforts, and 
contribute to research into the possibility of 
the use of pharmacological compounds to 
increase voluntary exercise motivation. 
The localization of NR2F1 in neurons was a 
step towards understanding its position in 
the brain, and will contribute to research 
involved in autism and other developmental 
disabilities. 
CLARITY itself is a fairly new technique with 
a lot of potential, both seen and unseen, for 
future purposes. The technique has 
potential for mapping neural circuits and 
other connectomics work, for classifying 
and subclassifying neurons, and for 
protein localization in other projects. 
Fig. 3 Above, GPR3 (in green) co-located 
with neurons, identified using the pan-
neuronal marker NeuN (in red).
After a transcardial perfusion, mouse brains are 
extracted and fixed in a 
paraformaldehyde/acrylamide solution. The 
brains are then sectioned on a vibrating 
microtome, and the slices incubated at 37oC for 
three hours, and then polymerized at 37oC for 
three hours. For Thick Slice CLARITY, rather 
than doing clearing by electrophoretic tissue 
clearing (ETC) methods, passive clearing over 
the course of two to three days in SDS-ETC 
solution at 37oC is more typical. After the lipids 
have been cleared from the tissue, the slices 
may undergo multiple rounds of antibody 
staining, and then may be mounted and 
imaged, generally via confocal microscopy.
Thick Slice CLARITY allows for the viewing of 
regional sections of the brain and analysis at a 
structural and molecular level. It has proven 
very useful for the localization of novel 
neuroactive target gene products.
Fig. 2, Right, GPR3 (in 
green) co-located with 
neurons (NeuN, in red) in a 
200 micron thick slice of 
mouse brain. 
This image was taken using 
a Zeiss LSM 700 confocal 
microscope after Thick Slice 
CLARITY techniques and 
antibody staining had been 
applied to the brain slices. 
Fig 4., Above, NR2F1 (in green) localized in 
neurons, identified with the pan-neuronal 
marker NeuN (in red) and cell nuclei. .
Recent research into mouse activity and 
exercise showed that there is a strong positive 
correlation between the expression levels of 
Gpr3, a gene encoding an orphan G-protein-
coupled receptor involved in signal 
transduction, and motivation for voluntary 
running activity in mice.3 Because of its density 
of dopamine receptors, the striatum was 
identified as a
brain region likely to 
have experienced 
changes at a 
molecular level as a 
result of changed 
intrinsic exercise 
motivation. 
The Thick Slice 
CLARITY 
technique, used in 
conjunction with
standard fluorescent staining methods and 
imaging via confocal microscopy, has allowed 
for the colocalization of GPR3 with neurons in 
the mouse striatum, verifying the hypothesis of 
the area’s importance. As seen on in Fig. 3, the 
small number of cells labeled with GPR3 
reinforces standing ideas of where Gpr3 is 
expressed. 
Similar techniques were employed to localize 
NR2F1, the product of a deeply conserved autism 
gene, in neurons in the brain. While previously 
known to be existent in the human brain, its 
localization was unknown.
It is important to 
note that NR2F1
expression, in 
green, is localized 
only in neurons, in 
red, and not in 
other cell types, 
such as glia, in 
blue. This 
distinction is 
important for work 
into the future. 
